Physician profile
Benjamin Kensing
NPI 1265016398
$1,482.35
in general payments reported to CMS, 2019-2025
8 companies · $338 in 2025
The $338 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $355 · 2023: $420 · 2024: $370 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,016 · Education: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,015.91 |
| Education | $111.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $462.33 | 2022-2024 | Photonsaber F, Spy-Phi System, 1788 |
| Astrazeneca Pharmaceuticals LP | $260.10 | 2023-2024 | |
| Abbvie INC. | $198.80 | 2024-2025 | |
| Octapharma USA, INC. | $160.01 | 2025 | Fibryga |
| Innovation Technologies INC | $149.77 | 2023 | Irrisept |
| Davol INC. | $105.70 | 2022 | |
| Avanos Medical | $86.82 | 2023 | On-Q* Pump and Accessories |
| Polynovo North America LLC | $58.82 | 2025 | Novosorb Btm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Kensing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.